Clincosm LogoSign in Get a demo

aml

Showing NaN - NaN of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDS, AML Trial in France (venetoclax + azacitidine +/- donor lymphocyte infusion)

Not yet recruiting
  • MDS
  • AML
  • venetoclax + azacitidine +/- donor lymphocyte infusion
  • Amiens, France
  • +13 more
Jul 21, 2022

MDS, AML Trial in France (ASTX727, Donor Lymphocyte Infusions)

Recruiting
  • MDS
  • AML
  • Amiens, France
  • +15 more
Jul 21, 2022

AML Trial in Worldwide (Flotetuzumab dose escalation, Flotetuzumab dose expansion, Ruxolitinib)

Active, not recruiting
  • AML
  • Flotetuzumab dose escalation
  • +2 more
  • Duarte, California
  • +42 more
Mar 7, 2022

AML Trial in Worldwide (Quizartinib, Salvage Chemotherapy)

Completed
Has Results
  • AML
  • Duarte, California
  • +130 more
Feb 2, 2021

MDS, AML, ALL Trial in France (Clofarabine in combination with IV busulfan and ATG)

Completed
  • MDS
  • +3 more
  • Clofarabine in combination with IV busulfan and ATG
  • Lyon, France
  • +5 more
Jul 18, 2017

AML Trial in France (Clofarabine)

Completed
  • AML
  • Bordeaux, France
  • +8 more
Dec 4, 2014

AML Trial in Nantes (Imatinib)

Completed
  • AML
  • Nantes, France
    Nantes University Hopspital
Jan 30, 2009